Viatris (VTRS) Earnings Date & Reports

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

VTRS is expected to report earnings to fall 4.65% to 51 cents per share on May 12

Q1'25

Est.

$0.51

Q4'24

Missed

by $0.04

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.01

Q1'24

Est.

$0.67

The last earnings report on February 27 showed earnings per share of 54 cents, missing the estimate of 57 cents. With 1.15M shares outstanding, the current market capitalization sits at 14.18B.

View a ticker or compare two or three

Compare

VTRS